弊社カスタマーサクセスサイエンティストの栗本綾子が日本核酸医薬学会 第9回年会（仙台）にてポスター発表いたします。 皆様と会場でお目にかかれることを楽しみにしております。 #massspectrometry #oligonucleotides #vaccines #biotherapeutics #proteomics Dotmatics #biosimilars #cdmo
About us
Protein Metrics' vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. For more information, visit http://www.proteinmetrics.com.
- Website
-
http://www.proteinmetrics.com
External link for Protein Metrics, LLC
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- BOSTON, MA
- Type
- Privately Held
- Specialties
- Biotechnology, Proteomics, Mass Spectrometry, Analytical Development, Computer Science, Algorithms, Data Mining, Life Sciences, Analytical Chemistry, Glycobiology, Biopharmaceuticals, Biosimilars, Protein Characterization, Antibodies, LCMS, Glycosylation, Biotherapeutics, LCMSMS, CE-MS, Higher Order Structure, Multi-Attribute Method, and MAM
Locations
-
Primary
Get directions
225 Franklin St, 26th Floor
BOSTON, MA 02110, US
Employees at Protein Metrics, LLC
Updates
-
Protein Metrics, LLC reposted this
📢자연과학이 Protein Metrics, LLC의 새로운 파트너가 되었습니다! Protein Metrics, LLC는 Mass spectrometry(MS) 분석에 특화된 소프트웨어의 선두 주자로, MS 장비 벤더에 관계없이 다양한 MS 결과를 통합하여 분석할 수 있는 혁신적인 솔루션을 제공합니다. 이번 파트너십을 통해 자연과학은 PROTEIN METRICS의 강력한 소프트웨어 제품을 국내 연구자들에게 소개하게 되어 매우 기쁩니다. PROTEIN METRICS의 BYOS는 단백질 분석에 특화된 통합 소프트웨어로, Antibody, Oligo, Peptide, Chromatogram 등 다양한 분석을 한 곳에서 처리할 수 있으며, One Click Reporting 기능을 통해 편리하게 리포팅을 자동화할 수 있습니다. 여러 프로그램을 사용할 필요 없이 단일 소프트웨어에서 다양한 분석을 처리할 수 있는 통합성과 자동 annotation, One Click Reporting 분석 자동화로 여러분의 연구가 더 효율적이고 정밀해질 수 있도록 도와드리겠습니다. 지금 자연과학에 문의하세요! #자연과학 #PROTEINMETRICS #단백질분석 #질량분석 #통합소프트웨어 #BYOS #공식대리점 #연구지원 #과학기술
-
-
７月23日（火）10時30分より、アジレントテクノロジー様と共催で核酸医薬品LC、LCMS分析の最新ソリューションについてウェビナーを開催します。最初にアジレント社より化学合成核酸、mRNAワクチンのLC,LCMS分析の革新的な技術とソリューションについてご紹介し、さらにプロテインメトリックス社からは、高い操作性のベンダーニュートラルなMSデータ解析ソフトウエアByosについてデモを交えてご紹介します。是非お見逃しなく！ https://bit.ly/3W5PGd7 #massspectrometry #oligonucleotides #vaccines #biotherapeutics #proteomics Dotmatics Agilent Technologies #biosimilars #cdmo
-
-
We had an amazing time at our symposium on "Automation and Smarter Workflows in Biotherapeutic Characterization" in Leiden, The Netherlands yesterday! A huge thank you to everyone who joined us, including our fantastic speakers from The Janssen Pharmaceutical Companies of Johnson & Johnson, RIC group, GSK, Leiden University Medical Center, and Utrecht University. Your insights and engagement made the event truly inspiring. Looking forward to continuing the conversations and advancements in this crucial field. Thank you all for making it such a success!
-
-
効率的なMAM解析ウェビナーのご案内です。Protein Metrics社の ByosphereやByosを使用することで 、質量分析データの複雑な解析が可能になり品質特性解析の効率が向上します。本ウェビナーではByosを用いた効率的な解析、Byosphereのディープクエリ機能によるプロジェクト横断的な解析結果の検索、ダッシュボード機能などをライブデモでご紹介します。皆様のご参加をお待ちしております。 https://bit.ly/3xroqMO #massspectrometry #oligonucleotides #vaccines #biotherapeutics #proteomics #biosimilars Dotmatics #cdmo
-
-
Exciting news! SHIMADZU CORPORATION and Protein Metrics, LLC have strengthened their agreements to enhance data interoperability, benefiting their mutual customers. This collaboration focuses on improving data reading capabilities between Byos products and LabSolutions, showcasing their commitment to GxP and 21 CFR Part 11 compliance, data management, and chain of custody capabilities. Eric Carlson, President of Protein Metrics, expressed enthusiasm about the integration, emphasizing its role in eliminating data silos and accelerating decision-making. Takashi Shimada, Ph.D., from Shimadzu Corporation, highlighted the collaboration's potential to advance biopharmaceuticals by elucidating dynamic structural changes and providing new insights into immunological mechanisms. https://lnkd.in/dfE3iAai
-
-
Yihan L., a Senior Scientist at AbbVie, walks us through her teams latest poster: "A Novel in vitro Serum Stability Assay for Antibody Therapeutics Incorporating Internal Standards." Yihan explains her team's innovative approach to pre-animal testing screening for biologics, focusing on stable molecule identification through precise incubation and LC-MS analysis. Discover how the use of internal standards, including NISTmAb and its Fc fragment, improve data accuracy and quality - promising findings that could transform biologics screening! https://bit.ly/3z7B1oK Rosendo Villafuerte-Vega, Hetal Sarvaiya #massspectrometry #glycosylation #oligonucleotides #vaccines #biotherapeutics #proteomics Dotmatics #biosimilars #cdmo
-
Our Leiden Symposium is filling up - we have just posted an updated agenda to the registration page - with talks from The Janssen Pharmaceutical Companies of Johnson & Johnson, RIC group, GSK, Leiden University Medical Center and Utrecht University it promises to be an ideal occasion to gain insights and network with your local peers. Less than 3 weeks left - register today! See the agenda here: https://bit.ly/4bL4nI4
Join us for an inspiring day in Leiden, The Netherlands, at our symposium on "Automation and Smarter Workflows in Biotherapeutic Characterization." This is a fantastic opportunity to gain insights, network, and engage with both industry and academic leaders. We are excited to feature presentations from organizations such as The Janssen Pharmaceutical Companies of Johnson & Johnson, RIC group, GSK, Leiden University Medical Center, and Utrecht University. Be part of the conversation and advance your knowledge in this crucial field. Reserve your place now by clicking the link below. Don’t miss out! https://bit.ly/3w5CydH #massspectrometry #oligonucleotides #vaccines #biotherapeutics #proteomics Dotmatics #biosimilars #cdmo
-
-
Excited to share insights from the latest research at the University of Washington! Miklos Guttman's lab is pioneering advanced techniques in protein glycosylation analysis using mass spectrometry. They have developed innovative methods to accurately identify glycan structures and their precise locations on proteins, overcoming the limitations of traditional glycan profiling. By integrating MS2, MS3, and MS4 data, and collaborating with Protein Metrics to automate the analysis, we are pushing the boundaries of proteomics. This work has significant implications for understanding protein function and disease. Stay tuned for their upcoming publication! https://bit.ly/3KsYhA2 #massspectrometry #glycosylation #oligonucleotides #vaccines #biotherapeutics #proteomics Dotmatics #biosimilars #cdmo